FDA Drug information
GAMIFANT
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- GAMIFANT EMAPALUMAB 10 mg/2mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 100 mg/20mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 100 mg/4mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 250 mg/10mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 50 mg/10mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 50 mg/2mL Swedish Orphan Biovitrum AB (publ)
- GAMIFANT EMAPALUMAB 500 mg/20mL Swedish Orphan Biovitrum AB (publ)
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.